Qilan Qian
Jiangsu Key Laboratory Of Marine Pharmaceutical Compound Screening
Lianyungang, 222005, China
Lianyungang, 222005, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
FOXP4-mediated induction of PTK7 activates the Wnt/β-catenin pathway and promotes ovarian cancer development.
Journal: Cell death & disease
Published: February 12, 2024
CENPK orchestrates ovarian cancer progression via GOLPH3-Mediated activation of mTOR signaling.
Journal: Molecular and cellular endocrinology
Published: January 09, 2024
β-catenin/TCF4-induced SCUBE3 upregulation promotes ovarian cancer development via HIF-1 signaling pathway.
Journal: Molecular and cellular endocrinology
Published: August 25, 2023
FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression.
Journal: Cell death & disease
Published: August 20, 2023
JHD205, A Novel Abemaciclib Derivative, Exerts Antitumor Effects on Breast Cancer by CDK4/6.
Journal: Anti-cancer agents in medicinal chemistry
Published: July 20, 2023
USP14 regulates heme metabolism and ovarian cancer invasion through BACH1 deubiquitination and stabilization.
Journal: Biochemical and biophysical research communications
Published: April 02, 2023
The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development.
Journal: Cellular signalling
Published: December 15, 2022
Epigenetic reactivation of PEG3 by EZH2 inhibitors suppresses renal clear cell carcinoma progress.
Journal: Cellular signalling
Published: November 16, 2022
Identification of the deubiquitinase USP28 as a novel molecular therapeutic target of ovarian cancer.
Journal: Biochemical and biophysical research communications
Published: November 03, 2022
The USP18-FBXO6 axis maintains the malignancy of ovarian cancer.
Journal: Biochemical and biophysical research communications
Published: December 27, 2021
Last Updated: 09/26/2026